Connect with us

News

Rs. 1.4bn loss due to expiration of Pfizer vaccines

Published

on

The government has no plans to bring down the US-made Pfizer BioNTech vaccine against COVID-19 after about six million doses (about one million vials) expired this week, causing a whopping loss of Rs. 1.4 billion to the Government.

At the beginning of the vaccination drive against COVID-19, many people were not given the US-made Pfizer vaccine as their first and second doses. The limited amounts of Pfizer were restricted to those travelling overseas, cancer patients, and fisherfolk in the North and Northwestern coastal areas.

Health Services Deputy Director General Dr. Hemantha Herath told the Sunday Times that the Health Ministry had ended administering the US-made vaccine as the people had shown less interest in getting booster doses against the virus.

He said that despite 8.2 million people obtaining the first Pfizer booster dose (third dose) only 202,571 people had been administered the second booster shot (fourth dose).

The majority of the Pfizer vaccines were purchased by the Health Ministry, said Dr. Herath. The United States donated 1.9 million doses of Pfizer in partnership with COVAX, a World Health Organisation-led programme.

Dr. Saman Ratnayake, a former Secretary to the State Ministry of Pharmaceutical Products, Supply and Regulation, said the vials were bought in 2021 at USD 6-7 a vial when the dollar rate was Rs. 198.

According to the Epidemiology Unit, about 12 million doses of the Pfizer vaccine have been administered in Sri Lanka. More than 2.6 million people were given the Pfizer vaccine as the first dose, 1.1 million as the second dose, 8.3 million as the booster dose and just over 200,000 as the second booster dose.

The government has spent an estimated Rs. 52 billion for the purchase of the Pfizer vaccines.

The Health Ministry’s Chief Epidemiologist Dr. Samitha Ginige said the shelf life was extended from July 31 to October 31 after consultation with the WHO but still those who got the jab were less than expected.

Just after WHO’s confirmation of the shelf life, the government tried to donate six million doses to Myanmar with the assistance of the WHO but failed.

Health authorities said the vaccination drive to immunise school students with the Pfizer vaccine too failed due to frequent school closures. They say this year’s economic crisis, political unrest, transportation, and gas issues diverted the people’s attention away from the second booster dose.

“It is such a waste knowing millions of doses of Pfizer have expired. There were times people were desperately looking for Pfizer. Now there are no Pfizer vaccines in the country,” said Head of the Public Health Inspectors Union Upul Rohana.

He said the issue would arise for those travelling overseas seeking the Pfizer dose as the vaccine was currently not available even in the private sector.

“Most people didn’t have much choice ending up with the Indian-made Covishield or the Chinese-made Sinopharm. We as MPs were getting calls from well-known personalities seeking the Pfizer vaccine as the first and second doses,” said Opposition MP Kins Nelson who raised the vaccine concern in Parliament recently. The MP said the government should look into how such wastage of vaccines took place when there was actual demand for the specific vaccine.

COVID-19 claimed 16,781 lives and 671,110 persons have been confirmed to have contracted the virus since the first outbreak. At present Sinopharm is available at MoH-based vaccination centres.

(sundaytimes.lk)

(Except for the headline, this story, originally published by sundaytimes.lk has not been edited by SLM staff)

News

COVID subvariants spreading in Asia detected in Sri Lanka

Published

on

By

The Medical Research Institute of Sri Lanka has confirmed that the COVID-19 variant currently spreading in the Asian region has also been identified in the country.

Dr. Jude Jayamaha, a specialist in viral diseases at the Medical Research Institute, stated that patients infected with the Omicron subvariants LF.7 and XFG are being reported locally.

Dr. Jayamaha explained that this finding was confirmed through research conducted on biological samples collected from several hospitals across the island.

However, he emphasized that there is no need for undue fear regarding these COVID-19 variants.

Health authorities have also stressed the importance of vulnerable groups—such as pregnant mothers, the elderly, and those with chronic illnesses—following health guidelines, including wearing face masks and avoiding crowded places.

Dr. Jayamaha reiterated that new COVID-19 variants emerge periodically, and health authorities are continuously monitoring the situation, so the public should remain calm.

(newswire.lk)

(This story, originally published by newswire.lk has not been edited by SLM staff)

Continue Reading

News

Anudi misses out from Miss World Quarter-Finals

Published

on

By

The Miss World organization has announced its quarter-finalists, selecting 40 contestants from across Asia, Europe, Africa, and the Americas.

Sri Lanka’s Anudi Gunasekara, was not selected in the top 40, despite being recognized for her impressive performances in the Multimedia and Head-to-Head challenges.

The top 40 consisted of 10 contestants each from Asia & Oceania, Europe, Africa and the Americas.

Continue Reading

News

Fuel prices unchanged

Published

on

By

The Ceylon Petroleum Corporation (CPC) announced that there will be no revision of fuel prices for the month of June 2025.

Accordingly, all fuel prices will remain unchanged for June, it said.  

Existing fuel prices (per litre):

Auto Diesel – Rs. 274
Super Diesel – Rs. 325
Petrol 92 Octane – Rs. 293
Petrol 95 Octane – Rs. 341
Kerosene – Rs. 178

Continue Reading

Trending

Copyright © 2024 Sri Lanka Mirror. All Rights Reserved